CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment

Casein kinase 2 (CK2) is highly activated in Alzheimer disease (AD) and is associated with neurofibrillary tangles formation. Phosphorylated SET, a potent PP2A inhibitor, mediates tau hyperphosphorylation in AD. However, whether CK2 phosphorylates SET and regulates tau pathological phosphorylation in AD remains unclear. Here, we show that CK2 phosphorylating SET at Ser9 induced tau hyperphosphorylation in AD. We found that either Aβ treatment or tau overexpression stimulated CK2 activation leading to SET Ser9 hyperphosphorylation in neurons and animal models, while inhibition of CK2 by TBB abolished this event. Overexpression of CK2 in mouse hippocampus via virus injection induced cognitive deficit associated with SET Ser9 hyperphosphorylation. Injection of SET Ser9 phosphorylation mimetic mutant induced tau pathology and behavior impairments. Conversely co-injection of non-phosphorylated SET S9A with CK2 abolished the CK2 overexpression-induced AD pathology and cognitive deficit. Together, our data demonstrate that CK2 phosphorylates SET at Ser9 leading to SET cytoplasmic translocation and inhibition of PP2A resulting in tau pathology and cognitive impairments.

[1]  Leif E. Peterson,et al.  Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis , 2017, Journal of neuropathology and experimental neurology.

[2]  M. Schubert,et al.  Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease , 2017, Nature Communications.

[3]  P. Scheltens,et al.  Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology , 2016, Journal of Neuroinflammation.

[4]  William T. Hu,et al.  Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease , 2014, Nature Medicine.

[5]  I. Grundke‐Iqbal,et al.  Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau* , 2014, The Journal of Biological Chemistry.

[6]  J. Scheller,et al.  Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation , 2014, Oncotarget.

[7]  J. McGann,et al.  Fear Learning Enhances Neural Responses to Threat-Predictive Sensory Stimuli , 2013, Science.

[8]  B. Hyman,et al.  Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease , 2013, The Journal of Neuroscience.

[9]  Jian-Zhi Wang,et al.  Ser9 phosphorylation causes cytoplasmic detention of I2 PP2A/SET in Alzheimer disease , 2013, Neurobiology of Aging.

[10]  I. Grundke‐Iqbal,et al.  Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease* , 2013, The Journal of Biological Chemistry.

[11]  Carmen Gil,et al.  Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases , 2011, Medicinal research reviews.

[12]  I. Grundke‐Iqbal,et al.  Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2 PP2A/SET , 2011, FEBS letters.

[13]  M. Montenarh.  Cellular regulators of protein kinase CK2 , 2010, Cell and Tissue Research.

[14]  Seong-Jun Cho,et al.  RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability , 2010, Nucleic acids research.

[15]  I. Mook‐Jung,et al.  Constitutive JAK2/STAT1 activation regulates endogenous BACE1 expression in neurons. , 2009, Biochemical and biophysical research communications.

[16]  Barbara Guerra,et al.  Protein kinase CK2 in human diseases. , 2008, Current medicinal chemistry.

[17]  Zhixue Liu,et al.  Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. , 2008, Molecular cell.

[18]  Chunmei Zhao,et al.  Distinct Morphological Stages of Dentate Granule Neuron Maturation in the Adult Mouse Hippocampus , 2006, The Journal of Neuroscience.

[19]  G. Unger,et al.  Targeting CK2 for cancer therapy. , 2005, Anti-cancer drugs.

[20]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[21]  I. Grundke‐Iqbal,et al.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. , 2005, The American journal of pathology.

[22]  I. Grundke‐Iqbal,et al.  Inhibitors of protein phosphatase‐2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau , 2005, FEBS letters.

[23]  I. Grundke‐Iqbal,et al.  Inhibitors of protein phosphatase-2A: topography and subcellular localization. , 2004, Brain research. Molecular brain research.

[24]  O. Bachs,et al.  The SET Protein Regulates G2/M Transition by Modulating Cyclin B-Cyclin-dependent Kinase 1 Activity* , 2003, The Journal of Biological Chemistry.

[25]  R. Busse,et al.  CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane , 2002, Circulation research.

[26]  P. Blanquet.  Casein kinase 2 as a potentially important enzyme in the nervous system , 2000, Progress in Neurobiology.

[27]  E. Masliah,et al.  Casein kinase II alteration precedes tau accumulation in tangle formation. , 1992, The American journal of pathology.

[28]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[29]  P. Rudrabhatla.  Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases. , 2014, Journal of Alzheimer's disease : JAD.

[30]  Seong-Jun Cho,et al.  RNPC 1 modulates the RNA-binding activity of , and cooperates with , HuR to regulate p 21 mRNA stability , 2010 .

[31]  J. Wegiel,et al.  Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome. , 2008, Journal of Alzheimer's disease : JAD.

[32]  D. Litchfield.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.